Arrowhead Research reported $45.36M in Operating Expenses for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 136.48M 11.45M
Alnylam Pharmaceuticals ALNY:US $ 357.78M 6.73M
Arena Pharmaceuticals ARNA:US $ 122.38M 23.56M
Arrowhead Research ARWR:US $ 45.36M 12.39M
Bluebird Bio BLUE:US $ 214.69M 5.72M
Cerulean Pharma CERU:US $ 7.58M 455.99K
Dicerna Pharmaceuticals DRNA:US $ 72.6M 830K
Heron Therapeutics HRTX:US $ 81.9M 3.55M
Intercept Pharmaceuticals ICPT:US $ 123.87M 10.81M
Ligand Pharmaceuticals LGND:US $ 58.78M 20.68M
Merk MRK:US $ 14764M 5329M
Mirati Therapeutics MRTX:US $ 108.04M 7.94M
Moderna Inc MRNA:US 845.78M 452.76M
Nektar Therapeutics NKTR:US $ 134.18M 1.1M
Novartis NOVN:VX 10.39B 260M
Opko Health OPK:US $ 445.32M 39.19M
Spectrum Pharmaceuticals SPPI:US $ 39.57M 3.08M
Ultragenyx Pharmaceutical RARE:US $ 187.62M 55.84M
Vertex Pharmaceuticals VRTX:US $ 882.03M 16M
Xencor XNCR:US $ 55.55M 3.46M
YTE INCY:US $ 625.28M 9.96M